Literature DB >> 11773094

Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada.

D Greenberg1, D P Speert, E Mahenthiralingam, D A Henry, M E Campbell, D W Scheifele.   

Abstract

Distinctive international clones of penicillin-nonsusceptible and multidrug-resistant Streptococcus pneumoniae are increasingly being reported. We investigated the spread of these clones in Canada through an active surveillance that was carried out at 11 Canadian pediatric tertiary care centers from 1991 to 1998. All penicillin-nonsusceptible isolates were serotyped, tested for antibiotic susceptibility, and genotyped by pulsed-field gel electrophoresis (PFGE) and random amplified polymorphic DNA (RAPD). Forty-five penicillin-nonsusceptible S. pneumoniae isolates were evaluated. Eleven serotype 9V isolates and six serotype 14 isolates displayed identical RAPD and PFGE fingerprint profiles. Twelve (70%) of these isolates were encountered in Quebec. The 9V/14 clone and the Spanish-French clone had similar PFGE fingerprint patterns. Eight isolates of serotype 23F and two isolates of serogroup 14 had the same fingerprint profiles and displayed resistance to three or more antibiotic drug classes. This clone was first detected in Calgary (Alberta) and in 1996 appeared simultaneously in various regions of Canada. This clone showed a PFGE fingerprint pattern similar to that of the Spanish-U.S. 23F clone. Our data show the emergence across Canada of two international clones of penicillin-nonsusceptible S. pneumoniae: (i) serotypes 9V and 14 related to the Spanish-French clone and (ii) the 23F Spanish-U.S. clone. The source of the first clone was in Quebec and the second international clone was probably originated from the United States. The exact reasons for the successful spread of these clones within Canada and their contribution to increased resistance to antibiotics have yet to be explored.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773094      PMCID: PMC120104          DOI: 10.1128/JCM.40.1.68-74.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

Review 1.  Application of molecular typing to the epidemiology of Streptococcus pneumoniae.

Authors:  L M Hall
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

Review 2.  Molecular tools for epidemiologic study of infectious diseases.

Authors:  J J Lipuma
Journal:  Pediatr Infect Dis J       Date:  1998-08       Impact factor: 2.129

3.  Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel.

Authors:  P Yagupsky; N Porat; D Fraser; F Prajgrod; M Merires; L McGee; K P Klugman; R Dagan
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

4.  The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease.

Authors:  J D Kellner; A McGeer; M S Cetron; D E Low; J C Butler; A Matlow; J Talbot; E L Ford-Jones
Journal:  Pediatr Infect Dis J       Date:  1998-04       Impact factor: 2.129

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea.

Authors:  H J Lee; J Y Park; S H Jang; J H Kim; E C Kim; K W Choi
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

7.  Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics.

Authors:  C G Dowson; T J Coffey; B G Spratt
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

8.  Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group.

Authors:  J D Kellner; E L Ford-Jones
Journal:  Arch Pediatr Adolesc Med       Date:  1999-05

9.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.

Authors:  E Mahenthiralingam; M E Campbell; D A Henry; D P Speert
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

10.  Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria.

Authors:  L Setchanova; A Tomasz
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more
  5 in total

1.  Phenotypic and genotypic characterization of invasive Streptococcus pneumoniae clinical isolates.

Authors:  Abdulaziz M Al-Swailem; Ashraf A Kadry; Soliman I Fouda; Atef M Shibl; Omar H Shair
Journal:  Curr Ther Res Clin Exp       Date:  2004-09

2.  In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel.

Authors:  David Greenberg; Ron Dagan; Marie Muallem; Nurith Porat
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children.

Authors:  Anita L Kozyrskyj; Anita G Carrie; Garey B Mazowita; Lisa M Lix; Terry P Klassen; Barbara J Law
Journal:  CMAJ       Date:  2004-07-20       Impact factor: 8.262

5.  Impact of the revised penicillin susceptibility breakpoints for Streptococcus pneumoniae on antimicrobial resistance rates of meningeal and non-meningeal pneumococcal strains.

Authors:  Badria R Al-Waili; Sahar Al-Thawadi; Sami Al Hajjar
Journal:  Ann Saudi Med       Date:  2013 Mar-Apr       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.